Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Industry Avoids FDA's "Blunt Tools" With Safe Use Initiative Progress

This article was originally published in The Tan Sheet

Executive Summary

Efforts by firms and other pharmaceutical industry stakeholders to drive FDA's Safe Use Initiative agenda lower the likelihood of the agency intervening with enforcement action, according to Principal Deputy Commissioner Josh Sharfstein

You may also be interested in...



Dosing Directions, Measuring Devices Vary For OTC Meds, JAMA Study Says

Dosing directions and measuring devices for top-selling pediatric over-the-counter liquid medications were highly inconsistent as of November 2009, when the Food and Drug Administration issued voluntary industry guidelines in response to numerous reports of unintentional overdoses by children, according to a descriptive study of 200 such medications.

Dosing Directions, Measuring Devices Vary For OTC Meds, JAMA Study Says

Dosing directions and measuring devices for top-selling pediatric over-the-counter liquid medications were highly inconsistent as of November 2009, when the Food and Drug Administration issued voluntary industry guidelines in response to numerous reports of unintentional overdoses by children, according to a descriptive study of 200 such medications.

Dosing Directions, Measuring Devices Vary For OTC Meds, JAMA Study Says

Dosing directions and measuring devices for top-selling pediatric over-the-counter liquid medications were highly inconsistent as of November 2009, when the Food and Drug Administration issued voluntary industry guidelines in response to numerous reports of unintentional overdoses by children, according to a descriptive study of 200 such medications.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel